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The  World  Health  Organization  recommends  vaccination  of pregnant  women  for  seasonal  inﬂuenza  that
can also  protect  infants  aged  below  6 months.  We  estimated  incidence  and  disease  burden  of inﬂuenza
in  hospitalised  children  below  and  above  6 months  of  age  in Hong  Kong  during  a 6  year  period.  Discharge
diagnoses  for  all admissions  to public  Hong  Kong  Hospital  Authority  hospitals,  recorded  in a central
computerised  database  (Clinical  Management  System,  CMS),  were  analysed  for the  period  April  2005  to
March  2011.  Incidence  estimates  of inﬂuenza  disease  by  age  group  were  derived  from  CMS ICD  codes
487–487.99.  Laboratory-conﬁrmed  inﬂuenza  infections  from  a single  surveillance  hospital  were then
linked  to the CMS  entries  to assess  possible  over-  and  under-diagnosis  of  inﬂuenza  based  on  CMS codes
alone.  Inﬂuenza  was  recorded  as  any  primary  or any  secondary  diagnosis  in  1.3%  (1158/86,582)  of  infants
aged  above  6 days  to  below  6 months  and  4.3%  (20,230/471,482)  of  children  above  6  days  to  below 18
years.  The  unadjusted  incidence  rates  per  100,000  person-years  based  on any  CMS diagnosis  of inﬂuenza
in  all  admission  to Hong  Kong  public  hospitals  were  627  in  the below  2 months  of  age  group  and  1762 in
the  2 month  to below  6 month  group.  Incidence  of  hospitalisation  for  inﬂuenza  in children  was  highest
from  2 months  to  below  6 months.  In  the absence  of  vaccines  for children  below  6 months  of age, effective
vaccination  of  pregnant  women  may  have  a  signiﬁcant  impact  on reducing  inﬂuenza  hospitalisations  in
this age  group.
© 2014  The  Authors.  Published  by Elsevier  Ltd. This  is  an open  access  article  under  the  CC  BY-NC-SA
license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).Abbreviations: CMS, Clinical Management System; HA, Hospital Authority;
CD9-CM, International Classiﬁcation of Diseases; NPA, nasopharyngeal aspirates;
(H1N1)pdm09, 2009 pandemic inﬂuenza A (H1NI) virus; PWH, Prince of Wales
ospital; WHO, World Health Organization.
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Inﬂuenza is a burden to the Hong Kong healthcare system and
a signiﬁcant cause for hospitalisation among the paediatric pop-
ulation. Discharge diagnoses for all admissions to publicly funded
government (Hospital Authority, HA) hospitals in Hong Kong are
recorded in a central computerised database (Clinical Management
System, CMS) [1,2]. A 2002 study using the CMS  data showed hospi-
talisation rates in Hong Kong for inﬂuenza to be 3–10 times higher
than those reported for children in the United States, equating to
nearly 3% of children under 1 year old being hospitalised each year
due to inﬂuenza [3]. An analysis of the CMS  database for July 1997
through June 1999 for children aged less than 15 years reported a
primary diagnosis of a respiratory disorder in 37.5% of general pae-
diatric admissions [1]. CMS  diagnosis incidence rates of inﬂuenza
der the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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uring this 2-year period were 222–381 per 100,000 children under
 years and 415–528 per 100,000 children under the age of 1 year.
Following the outbreak of severe acute respiratory syndrome
n 2003, infection control measures in Hong Kong hospitals were
nhanced and many hospitals routinely collect nasopharyngeal
spirates (NPA) for all children with suspected respiratory infec-
ions. This situation has enabled us to analyse data collected
outinely through the CMS  system and combine this with enhanced
aboratory surveillance activities from one hospital to make esti-
ates of inﬂuenza disease burden in hospitalised children in Hong
ong. The current analysis compares data for infants aged below 6
onths with children below 18 years over a 6-year period (April
005–March 2011).
. Methods
This study protocol was approved by the Joint The Chinese Uni-
ersity of Hong Kong and New Territories East Cluster Clinical
esearch Ethics Committee.
.1. CMS  data
Information collected by the CMS  includes patient identiﬁers,
ate of birth, sex, a maximum of 15 diagnoses and 15 procedures
classiﬁed by International Classiﬁcation of Diseases ICD9 and ICD9-
M codes), and admission and discharge dates [1]. The CMS  was
olled out from 1996, and by mid-1997 this information was  avail-
ble for all HA hospitals. Prior to 2000, the majority of HA hospitals
nly coded the primary diagnosis for most hospital admissions. A
atabase of all paediatric patients admitted to general paediatric
nd neonatal wards from 1 April 2005 to 31 March 2011 was pro-
ided by the HA. Respiratory-associated admissions for children
ged above 6 days to below 6 months and above 6 days to below 18
ears were assessed by these ICD diagnostic groups and by hospital
f admission, outcome status (died, discharged home with or with-
ut follow-up and transferred to another hospital) and severity as
easured by the length of stay. Infants below 7 days of age were
xcluded from these initial analyses as the large majority of these
nfants were admitted during the immediate post-partum period
ue perinatal and neonatal problems.
able 1
ny inﬂuenza diagnosis reported from Clinical Management System (CMS) compared wit
atients aged below 18 years who had specimens sent for testing (1 April 2005 to 31 Mar
Year Total
admissions
LAB
ﬂu+/CMS
ﬂu+a
LAB
ﬂu+/CMS
ﬂu−a
LAB
ﬂu−/CMS
ﬂu+a
Primary
respiratoryb
Primary
respiratory
NPAc NOT
sent
0 to <2m 19,883 9 7 5 267 124 
2  to <6m 3211 110 9 6 813 47 
6m  to <1y 4000 131 23 20 1228 129 
1  to <2y 5221 266 40 42 1728 284 
2  to <5y 10,000 611 128 67 3465 354 
5  to <10y 7604 568 104 62 2294 308 
10  to 14y 4987 205 27 22 824 120 
14  to <18y 5031 93 21 29 444 124 
<5y  42,315 1127 207 140 7501 938 
Total  59,937 1993 359 253 11,063 1490 
a LAB ﬂu+ = laboratory test positive for inﬂuenza (Inﬂuenza A and B); LAB ﬂu− = laborat
ystem  diagnosis of inﬂuenza (ICD = 487–487.99); CMS  ﬂu− = Clinical Management Syste
b Primary respiratory = Clinical Management System diagnosis reports a primary resp
86.2]; tonsillitis/pharyngitis [462–463.9, 034.0, 474.11]; croup/laryngitis [464–464.9,
90–490.9, 519.8]; bronchiolitis [466.1–466.9]; pneumonia [480–486.9, 507.0]; inﬂuenza
c NPA: nasopharyngeal aspirate.
d Adjustment factor 1 = LAB ﬂu+/CMS ﬂu+.
e Adjustment factor 2 = [LAB ﬂu+] + [primary respiratory associated diagnosis and NPA 
f Adjustment factor 3 = LAB ﬂu+/total admissions by age group.32 (2014) 6692–6698 6693
2.2. Laboratory methods for inﬂuenza diagnosis at Prince of
Wales Hospital
Since 2003 NPA are collected for all children with suspected
respiratory infections at PWH  as a standard procedure as part of
routine care. At PWH  during the periods March 2005 to March 2006
[4], and October 2008 to March 2011 enhanced diagnostics were
available to document additional viral and bacterial pathogens.
All specimens are subjected to respiratory virus detection by the
immunoﬂuorescence (IF) test and/or conventional virus culture as
described previously [5].
2.3. Linking of CMS with laboratory data for Prince of Wales
Hospital
Laboratory data for all paediatric admissions from PWH  were
matched on the unique hospital number with the CMS  data. Age-
related analyses were based on the CMS  calculated dayage (date
of admission minus date of birth in days) and monthage (dayage
divided by 30.4). The laboratory dataset used for analysis only
included a single hospital number and a single laboratory request
number i.e. a single entry with a positive result was chosen if more
than two  NPA specimens were sent during the admission.
2.4. Calculation of inﬂuenza hospitalisation incidence rates by
age group from CMS discharge diagnosis
Incidence rates of hospitalisation for inﬂuenza for all HA hos-
pitals in Hong Kong were ﬁrst estimated from the total number of
children with any CMS  diagnosis of inﬂuenza (ICD-CM 487–487.9)
(CMS ﬂu+). Infants below 7 days of age were included in this inci-
dence analysis. These initial unadjusted CMS  ﬂu incidence rates for
each year by age were calculated with the following formula:(
x/y
z
)
× 100, 000where x is the number of admissions by age with any CMS  inﬂuenza
diagnosis (ICD-CM 487–487.9) and y is the admissions to public HA
hospitals as a percentage of total admissions by age (Appendix 1).
h actual results from the virology laboratory of the Prince of Wales Hospital for all
ch 2011).
b
AF1 d
calculated
AF1 d
mean
value
used
AF2e
calculated
AF2e
mean
value
used
AF3f
calculated
value
weighted by
age group
AF3f
smoothed
value
weighted by
age group
1.14 1.05 1.48 1.13 0.0008 –
1.03 1.05 1.05 1.13 0.0371 0.0351
1.02 1.05 1.07 1.13 0.0385 0.0427
0.99 1.05 1.09 1.13 0.0586 0.0552
1.09 1.05 1.16 1.13 0.0739 0.0739
1.07 1.05 1.18 1.13 0.0884 0.0880
1.02 1.05 1.14 1.13 0.0465 0.0474
0.93 1.05 1.12 1.13 0.0227 0.0230
1.05 1.05 1.13 1.13 0.0315 0.0348
1.05 1.05 1.13 1.13 0.0392 0.0422
ory test negative for inﬂuenza (Inﬂuenza A and B); CMS  ﬂu+ = Clinical Management
m diagnosis NOT inﬂuenza (not ICD = 487–487.99).
iratory-associated diagnosis (upper respiratory infection [460–461.9, 465–465.9,
 786.1]; acute otitis media [381–382.9]; bronchitis/chest infection [466–466.09,
 [487–487.9]; asthma/allergic rhinitis [493–493.9, 477–477.9]).
NOT sent * (LAB ﬂu+/NPA sent)]/CMS ﬂu+.
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These proportions were weighted by the number of admissions
hen incidence estimates were calculated for different age groups:
∑
j(Admissionsj × Pj)∑
jAdmissionsj
here Admissionsj is the number of admissions in the jth age group,
nd Pj is the proportion of admissions to HA hospitals in the jth age
roup; z is the estimated resident population by age (Appendix 2).
Incidence rates were calculated by monthly age groups and then
e-grouped according to different age ranges (Table 1).
.5. Calculation of adjustment factors
Since a CMS  ﬂu diagnosis may  reﬂect both under- and over-
iagnosis, we applied adjustment factors to this CMS  Flu derived
ncidence estimate (Table 1). These factors were derived by link-
ng the PWH  laboratory surveillance data (LAB ﬂu+ or LAB ﬂu−)
ith the PWH  CMS  data (CMS ﬂu+ or CMS  ﬂu−)  (Appendix 3).
he ﬁrst factor was derived to adjust for potential under-reporting
f inﬂuenza infection by the CMS  system. The second factor was
erived to reﬂect the potential under-estimation of a PWH  labora-
ory diagnosis of inﬂuenza by accounting for the fact that not all
dmissions with a primary respiratory-associated diagnosis had a
PA specimen sent to the laboratory for testing. The third factor
as the proportion of all admissions to PWH  by age group that had
 laboratory conﬁrmed diagnosis of inﬂuenza. No assessment or
djustment was made for possible nosocomial infections.
. Results
.1. CMS  diagnoses by age group for all HA hospitals
During the 6-year study period 1 April 2005 to 31 March 2011,
here were 624,916 children admitted to the paediatric medical
ards of all HA hospitals; 2 had no gender speciﬁed and 86 had
issing age data and were excluded. Of the 624,828 children with
alid data, 94.5% (590,683) were below the age of 18 years and
2.9% (205,783) were below the age of 6 months, 13.9% (86,582)
ig. 1. Seasonality of admissions with a discharge diagnosis of inﬂuenza (ICD9-CM 487–4
bottom row).32 (2014) 6692–6698
were aged above 6 days to below 6 months (6M group) and 75.5%
(471,482) were aged above 6 days to below 18 years (18Y group).
In the 6M and 18Y groups respiratory-associated disorders were
respectively coded as the primary diagnosis in 13.9% and 27.2%
of admissions, and as the primary or as one of any 9 secondary
diagnoses in 15.7% and 31.8% (Appendix 4).
The percentage of all discharges with a primary diagnosis and
“any” diagnosis of inﬂuenza (CMS ﬂu) ranged from 0.3% to 1.4% and
0.4 to 1.9% in the 6M group and from 0.9% to 4.2% and 1.3% to 6.0%
in the 18Y group respectively in the 12 HA hospitals (Appendix 5).
Likewise rates of admissions coded as having a respiratory illness
varied considerably between these different hospitals. Inﬂuenza
admissions peaked during February and September (Fig. 1). Over
the full 6 year study period there was a peak of admissions dur-
ing the April 2009–March 2010 (Fig. 1). A similar pattern was seen
with the data from all HA hospitals and with data from PWH  alone
(Fig. 1).
3.2. Linking laboratory inﬂuenza diagnosis to CMS  diagnoses at
Prince of Wales Hospital
After linking the CMS  data to the laboratory surveillance data
at PWH, there were 8325 admissions in the 6M group and 45,168
in the 18Y group that could be matched on their hospital num-
ber (Appendix 6). There were 18,002 records in the laboratory
database of which 17,783 could be matched with the hospital num-
ber to the CMS  data and included in the analysis. The remaining
219 records were either not within the age range or could not be
matched with their hospital number. In the 6M and 18Y groups,
NPAs were requested on 2066 (24.8%) and 17,783 (39.4%) admis-
sions (Appendix 7) and were positive in 6.5% (range 4.8–9.9%)
and 13.2% (range 9.2–21.5%) during the 6 year period respectively
(Appendix 8). Overall 1.6% of admissions in the 6M group and 5.2%
in the 18Y group had a positive NPA for inﬂuenza (Appendix 7).
In both age groups the highest positivity rate was  in the 2009/10
period during which time the 2009 pandemic inﬂuenza A (H1NI)
virus (A(H1N1)pdm09) inﬂuenza strain circulated but this effect
was less marked in the 6M group (Appendix 8). In all HA hospitals
the proportion of all admissions, and the proportion of admis-
sions to general wards and intensive care units, that had a CMS
87.9) for all Hospital Authority Hospitals (top row) and for Prince of Wales Hospital
E.A.S. Nelson et al. / Vaccine 32 (2014) 6692–6698 6695
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3.5. Length of stay and outcome
The median hospital stay for a CMS  diagnosis of inﬂuenza was 2
days (interquartile range 1.3) in both 6M and 18Y groups (Appendix
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AF3Fig. 2. Incidence of hospitalised inﬂuenza by age (0 to below 18 y
iagnosis of inﬂuenza was almost double during the 2009/10 period
Appendix 9).
.3. Calculation of adjustment factors
Including all children from 0 days to below 18 years, 1993
ad both a laboratory positive result and CMS  diagnosis (ICD9-CM
87–487.9) of inﬂuenza (Table 1). There were an additional 359
hildren without a CMS  diagnosis of inﬂuenza but with a laboratory
onﬁrmed result, and 253 with a CMS  diagnosis of inﬂuenza but
ithout laboratory conﬁrmation. This indicates that a CMS  diag-
osis of inﬂuenza under-estimates disease burden relative to the
aboratory results despite wide and routine laboratory testing with
PAs in children with fever or respiratory illnesses. Since there
ppeared to be no obvious age effect (Appendix 3) an overall mean
alue of 1.05 was used for adjustment factor 1 for all age groups. Of
he 11,063 children with a primary-respiratory associated diagno-
is, 1490 did not have an NPA sent. Adjustment factor 2 assumed
he inﬂuenza positive rate in these 1490 children was the same as in
he 9573 children that had an NPA sent (Table 1). Again this factor
id not appear to vary consistently with age and overall mean value
f 1.13 was applied to all age groups (Appendix 3). Adjustment fac-
or 3 was the proportion of all admissions by age group that had
 laboratory diagnosis of inﬂuenza at PWH  (Table 1). This factor
aried by age group and a smoothed value excluding the ﬁrst two
onths was applied to each monthly age group for the complete
A dataset (Appendix 3).
.4. Unadjusted and adjusted inﬂuenza incidence estimates for
ong Kong
The incidence rates of hospitalisation for inﬂuenza per 100,000
erson-years based on any CMS  inﬂuenza diagnosis (CMS ﬂu) for
he whole of Hong Kong were lowest in the ﬁrst two months of life,
hen peaked between 2 and 6 months, and then declined from about
 to 4 years of age (Figs. 2 and 3). Similar patterns were observed
ver the full 6 years of the study. The unadjusted incidence rates
er 100,000 person-years based on any CMS  diagnosis of inﬂuenzaand admission year, Hong Kong (1 April 2005 to 31 March 2011).
in all admission to Hong Kong public hospitals were 627 in the
below 2 months of age group; 1762 in the 2 month to below 6
month group; 1677 in the 6 month to below 1 year group; 1408
in the 1 to below 2 years group; 1081 in the 2 to below 5 years
group; 409 in the 5 to below 10 years group; and 137 in the 10 to
below 14 years group; and 81 in the 14 to below 18 years group
(Table 2). Incidence rates were highest in the A(H1N1)pdm09 year
(April 2009 to March 2010) (Table 2, Fig. 2). Adjusted incidence
rates were generally in a similar range to the unadjusted rates with
the exception of those rates estimated using adjustment factor 3
– in most years this estimate was higher than the other estimates,
whereas in the A(H1N1)pdm09 year it was lower (Fig. 2).Age
Fig. 3. Incidence of hospitalised inﬂuenza (ICD9-CM 487–487.9) by age group with
and  without application of adjustment factors derived from laboratory surveillance
at  one hospital, Hong Kong (1 April 2005 to 31 March 2011).
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Table  2
Incidence rates for hospitalisation with inﬂuenza per 100,000 person-years in Hong Kong (1 April 2005 to 31 March 2011).
All years 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11
Estimates based on ANY CMS diagnosis of inﬂuenza (ICD9-CM 487–487.9) with no adjustment
0  to <2m 627 796 469 509 367 714 887
2  to <6m 1762 1665 1306 1700 1286 2235 2286
6m  to <1y 1677 1134 1190 1380 1184 3034 1961
1  to <2y 1408 1025 1154 1017 1098 2290 1661
2  to <5y 1081 739 807 926 757 1901 1343
5  to <10y 409 310 211 314 264 984 452
10  to 14y 137 78 46 61 67 486 114
14  to <18y 81 37 24 23 41 301 66
<5y  1295 924 976 1075 934 2188 1591
Estimates based on ANY CMS diagnosis of inﬂuenza (ICD9-CM 487–487.9) with adjustment for under- and over-CMS ﬂu diagnosis based on data from Prince of Wales Hospital
(factor 1)a
0 to <2m 656 834 491 533 385 748 929
2  to <6m 1845 1744 1367 1781 1346 2340 2394
6m  to <1y 1756 1188 1247 1446 1239 3177 2054
1  to <2y 1475 1073 1209 1065 1150 2398 1739
2  to <5y 1133 773 845 969 792 1990 1407
5  to <10y 428 325 221 329 276 1030 473
10  to 14y 144 81 48 64 70 509 120
14  to <18y 85 39 25 24 43 315 69
<5y  1356 968 1022 1125 978 2292 1667
Estimates based on ANY CMS diagnosis of inﬂuenza (ICD9-CM 487–487.9) with adjustment for under- and over-CMS ﬂu diagnosis and failure to send NPA on all
respiratory-related admissions based on data from Prince of Wales Hospital (factor 2)a
0 to <2m 745 947 557 605 437 849 1054
2  to <6m 2093 1979 1552 2021 1528 2655 2716
6m  to <1y 1993 1348 1415 1640 1407 3605 2330
1  to <2y 1673 1218 1372 1208 1305 2721 1974
2  to <5y 1285 878 958 1100 899 2259 1597
5  to <10y 486 369 251 374 313 1169 537
10  to 14y 163 92 54 73 80 577 136
14  to <18y 97 44 28 27 49 358 78
<5y  1539 1099 1159 1277 1110 2601 1891
Estimates based on assumption that laboratory conﬁrmed inﬂuenza admissions as a proportion of all admissions by age group identiﬁed in Prince of Wales Hospital (active
surveillance) is the same proportion of all admission to all HA hospitals (factor 3)a
0 to <2m 1493 1580 1323 1438 1365 1540 1695
2  to <6m 2587 2757 2518 2914 2582 2375 2444
6m  to <1y 2354 2392 2466 2533 2406 2275 2105
1  to <2y 1737 1532 1975 1715 1898 1675 1661
2  to <5y 1310 1128 1218 1295 1331 1435 1448
5  to <10y 521 513 481 483 501 539 630
10  to 14y 162 160 165 150 145 177 183
14  to <18y 77 72 74 70 75 86 84
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inﬂuenza hospitalisation (CMS ﬂu) for all admissions to HA hos-
pitals in Hong Kong were 627 in the below 2 months age group
and peaked at 1762 in the 2 months to below 6 months age group.
Table 3
Laboratory conﬁrmed inﬂuenza cases associated with length of hospital stay, Prince
of Wales Hospital, Hong Kong from 1 April 2005 to 31 March 2011.
Total <2 days 2 days >2 days
H3N2 601 219 (36.4%) 206 (34.3%) 176 (29.3%)
H1N1 316 102 (32.3%) 104 (32.9%) 110 (34.8%)
pH1N1a 696 300 (43.1%) 186 (26.7%) 210 (30.1%)
NDb 222 77 (34.7%) 77 (34.7%) 68 (30.1%)
Inﬂuenza B 517 168 (32.5%) 129 (25.0%) 220 (42.6%)<5y  2906 2670 2781 
a See text for description of three adjustment factors.
0). This was less than for those children coded as having lower
espiratory infections (bronchitis, chest infection, bronchiolitis and
neumonia). Eleven of 549 recorded deaths had a CMS  diagnosis of
nﬂuenza, but in only two children was this recorded as the primary
iagnosis and none of these were in the 6M group (Appendix 11).
hildren with inﬂuenza were more likely to be discharged home
ithout follow-up. This pattern was similar to those children with
ther respiratory-associated diagnoses but overall children were
ore commonly discharged with follow-up.
The median length of stay for the laboratory conﬁrmed inﬂuenza
dmissions at PWH  were also 2 days (interquartile range 1.3 days)
or most of the study years and for most of the inﬂuenza types
Appendix 12). However by categorising length of stay into three
roups (<2 days, 2 days, >2 days), there were signiﬁcant differences
etween the different inﬂuenza types with more children admitted
ith inﬂuenza A(H1N1)pdm09 having stays of less than 2 days and
ore children with inﬂuenza B having longer stays (Table 3).
. DiscussionIn the recent recommendations issued by the World Health
rganization for seasonal inﬂuenza vaccines [6], pregnant women
ere listed as the highest priority with the view that maternal2871 2957 3018 3107
immunisation will offer protection for children below 6 months
of age since there are currently no vaccines licensed for this age
group. Our study aimed to assess the disease burden of inﬂuenza-
associated hospitalisation for young infants below 6 months of age
in Hong Kong. Our results indicated that the unadjusted incidence
rates per 100,000 person-years based on any CMS diagnosis ofThe p-value of Pearson Chi squared test is <0.001.
a 2009 pandemic inﬂuenza (H1N1) virus (A(H1N1)pdm09)
b Not determined: subtype not available, as inﬂuenza A was conﬁrmed only by
antigen detection by IF or DNA detection by RT-PCR of M gene of inﬂuenza A.
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Table  4
Comparative hospitalised inﬂuenza incidence estimates per 100,000 person-years by age by study period, Hong Kong.
Study period 0–2m 2 to <6m 6m to <1y 1–2y 2 to <5y 5 to <10y 10 to <14y 14 to <18y Reference
CMS Flu Apr 2005–Mar 2011 627 1762 1677 1408 1081 409 137 81 Current
study
CMS  Flu adjusted by
factor 1
Apr 2005–Mar 2011 656 1845 1756 1475 1133 428 144 85 Current
study
CMS  Flu adjusted by
factor 2
Apr 2005–Mar 2011 745 2093 1993 1673 1285 486 163 97 Current
study
CMS  Flu adjusted by
factor 3
Apr 2005–Mar 2011 1493 2587 2354 1737 1310 521 162 77 Current
study
Oct  2003–Sep 2006 389–1038 409–955 381–595 109–219 15–29 (10
to <15y)
24–48 (15
to <18y)
[7]
Jan 1997–Dec 1999 2785–2882 2093–2184 773–1256 209–573 81–164 (10 – [3]
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e previously reported incidence rates per 100,000 for the period
997–1998 that were substantially less than our current estimates
Table 4) [1], possibly reﬂecting that NPAs were not routinely
equested for all respiratory-associated admissions prior to the
utbreak of severe acute respiratory syndrome in 2003. It is also
ikely that the overall incidence rates in our current study have
een inﬂated by the increased numbers of inﬂuenza admissions
uring the A(H1N1)pdm09 pandemic period during 2009/10. Our
urrent rates are also higher than those of another recent Hong
ong study [7], but lower than those of an earlier report by the
ame group (Table 4) [3]. However, the burden of disease alters
n relation to both the vaccine coverage in these children and the
rotection elicited by the vaccines that covered the circulating
irus strain types of the respective seasons. We  were unable to
ifferentiate between cases infected with vaccine-covered or non-
accine-covered strains as not all patients had their virus isolates
haracterised. However, based on the data provided by the National
nﬂuenza Reference Laboratory (personal communications), the
rivalent vaccine strains matched with our circulating strains in
005 and 2010; and incomplete match occurred with inﬂuenza A
3 strains for 2006 and 2011. For 2007 and 2009, the inﬂuenza A
1N1 strains were not matched while inﬂuenza B strains were not
atched in 2008. However, data suggested the uptake rate among
nfants 6–23 months was low at 8.5% during the 2005/6 ﬂu season
8], but the introduction of governmental subsidies to inﬂuenza
accination for aged 6–59 months since 2008 may  have improved
accine uptake.
Pregnant women are a high risk group that can beneﬁt from
easonal inﬂuenza vaccination and recent studies have suggested
hat their infants will also enjoy some degree of protection [9–16].
The vaccination uptake rate among pregnant women in Hong
ong is low in general, and ranged between 1.7 and 4.9% from
arious studies reported during this period [17–19]. Should a vacci-
ation programme targeting pregnant women also reduce the high
nﬂuenza incidence of hospitalisation in infants aged 2 months to
elow 6 months, it is likely that vaccine uptake would increase and
ost-effectiveness of the programme would be enhanced.
In contrast to high inﬂuenza hospitalisation rate in infants aged
 months to below 6 months was the low rate in infants below two
onths of age (627 per 100,000). This low rate was  despite the high
bsolute numbers of infants admitted during the ﬁrst two  months
f life (Table 1). A US study has shown that infants below 3 months
f age are more likely to present with fever alone than children aged
 months to below 24 months of age, and although they generally
o well and have a shorter duration of hospital stay, they are more
ikely to be admitted [20].This analysis shows the potential of combining laboratory
urveillance and passive discharge diagnosis surveillance to mon-
tor disease burden of vaccine-preventable pathogens [1,2]. Using
aboratory surveillance from one or more sentinel sites, it is possibleto <16y)
[1]
[1]
to monitor disease coding and revise estimates of disease burden
based on discharge diagnoses. However even with a practice of rou-
tine NPA testing for respiratory related illness, not all children will
have specimens collected for laboratory conﬁrmation. In our anal-
ysis we  have made estimates of possible increased disease burden
had all children had specimens taken. The laboratory surveillance
at PWH  suggested that up to 1.6% of infants aged above 6 days and
below 6 months of age and 5.2% of children aged above 6 days to
below 18 years are admitted to hospital as a result of inﬂuenza
infection. We adjusted the CMS  ﬂu diagnosis estimates using fac-
tors derived from linking our laboratory surveillance results at
PWH to the CMS  coded diagnoses and then extrapolated these
adjustments to the whole of Hong Kong. These adjusted rates were
generally higher than the unadjusted rates (Figs. 2 and 3). During
the A(H1N1)pdm09 pandemic in 2009/10 the proportion of chil-
dren aged above 6 days to below 18 years admitted to hospital
who had a diagnosis of inﬂuenza almost doubled (9.8%). Reasons
for this increase incidence during 2009/2010 could reﬂect a genuine
increase in disease burden or alternatively it could reﬂect changes
in admission policy e.g. all suspected A(H1N1)pdm09 infections,
including mild cases, were recommended for admission. Measures
for severity of illness in the current study were length of stay,
intensive care unit admission and outcome. Severity of inﬂuenza
as measured by mortality and length of stay did not appear to
be greater in the 6M group as compared to the 18Y group. The
median length of stay for the A(H1N1)pdm09 admissions was  sim-
ilar to the that of the non-A(H1N1)pdm09 inﬂuenza admissions
(Appendix 12) but when categorised into groups, a greater pro-
portion of children with A(H1N1)pdm09 had a length of stay less
than 2 days (Table 3), possibly reﬂecting less severe disease or a
greater proportion of admissions with mild disease. However the
number of intensive care unit admissions with any CMS diagnosis
of inﬂuenza was  highest during 2009/10. Incidence estimates based
on adjustment factor 3 (PWH laboratory conﬁrmed inﬂuenza rate)
tended to be higher than the other incidence estimates except dur-
ing 2009/10 (Fig. 2), possibly reﬂecting a sustained high level of
routine NPA testing for inﬂuenza during the whole study period at
PWH, but with other HA hospitals only increasing their NPA testing
for inﬂuenza from 2009/10.
Limitations to our incidence estimates include a number of
assumptions related to admissions to public HA hospitals and the
resident Hong Kong population. The proportion of admissions to
public hospitals has fallen in recent years and there has been a
marked increase in the number of mothers from mainland China
delivering in Hong Kong. It is possible that as a result of these
social trends our incidence estimates (Table 2) are likely to be
under-estimates rather than over-estimates since they exclude
inﬂuenza admissions to hospitals in mainland China. Conversely
our adjustment for under-testing (adjustment factor 2) could over-
estimate true incidence since it is possible that children who are
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ot tested represent a different clinical spectrum of disease, mak-
ng invalid the assumption that the proportion of inﬂuenza positive
ases in the untested group is the same as in the tested group. We
lso did not make any adjustments for children readmitted to the
ame or different HA hospital with the same inﬂuenza infection
nd for possible nosocomial infections which could have led to
n over-estimation of incidence. It is also likely that children with
osocomial inﬂuenza will have a longer length of stay, emphasis-
ng that length of stay does not consistently reﬂect disease severity.
e have also assumed that the adjustment factors derived from one
nstitution, PWH, can be applied uniformly across all the HA hos-
itals, and that these factors are stable over time. Although PWH  is
ne of the largest HA hospitals accounting for about 10% of all the
ublic hospital paediatric admissions, it is possible that there may
e differences in clinical practices, admission policies and labora-
ory services between PWH  and other HA hospitals and also over
ime.
. Conclusion
Estimates of the incidence of inﬂuenza that requires hospital
dmission were higher in children less than 5 years of age. Inci-
ence per 100,000 person-years was particularly high for infants
ged 2 months to below 6 months of age (1762) but lower in
hose below two months of age (627). Overall these estimates are
igher than our previous 1997–1998 estimates but similar to other
ong Kong estimates. Although a higher positivity rate for inﬂuenza
as noted during the 2009/10 inﬂuenza surveillance period when
(H1N1)pdm09 started to circulate, this could reﬂect a permis-
ive admission policy rather than increased disease burden and/or
everity. Our data support the recommendation that effective vac-
ination of pregnant women is likely to have a signiﬁcant impact
n reducing disease burden in young infants below 6 months of age
ospitalised for inﬂuenza.
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